Table 3.
Timing of coronary angiography and revascularisation in ESC risk groups
| NSTE-ACS patients (n = 871) | ||||
|---|---|---|---|---|
| Overall | Very high | High | Intermediate | |
| (n = 871) | (n = 56) | (n = 486) | (n = 256) | |
| Coronary angiography | ||||
| Angiography | 738/871 (84.7) | 48/56 (85.7) | 395/486 (81.3) | 229/256 (89.5) |
| Angiography at non-PCI centre | 480/871 (55.1) | 6/56 (10.7) | 250/486 (51.4) | 166/256 (64.8) |
| Angiography at PCI centre | 217/871 (24.9) | 39/56 (69.9) | 123/486 (25.3) | 48/256 (18.8) |
| Angiography at non-PCI and PCI centrea | 41/871 (4.7) | 3/56 (5.4) | 22/486 (4.5) | 15/256 (5.9) |
| No angiography | 102/871 (11.7) | 8/56 (14.3) | 72/486 (14.8) | 16/256 (6.3) |
| Unknown | 31/871 (3.6) | 0/56 (0.0) | 19/486 (3.9) | 11/256 (4.3) |
| Timing of coronary angiography | ||||
| Angiography <2 h | 71/636 (11.2) | 23/40 (57.5) | 34/337 (10.1) | 11/196 (5.6) |
| Angiography 3–24 h | 299/636 (47.0) | 8/40 (20.0) | 171/337 (50.7) | 90/196 (45.9) |
| Angiography <24 h | 370/636 (58.2) | 31/40 (77.5) | 205/337 (60.8) | 101/196 (51.5) |
| Angiography 25–72 h | 207/636 (32.5) | 5/40 (12.5) | 96/337 (28.5) | 79/196 (40.3) |
| Angiography <72 h | 557/636 (90.7) | 36/40 (90.0) | 301/337 (89.3) | 180/196 (91.8) |
| Heart team | ||||
| Discussed by Heart Team | 366/871 (42.0) | 12/56 (21.4) | 200/486 (41.2) | 123/256 (48.0) |
| Treatment | ||||
| Revascularisation | 471/871 (54.1) | 34/56 (60.7) | 267/486 (54.9) | 142/256 (55.5) |
| PCI | 376/871 (43.2) | 30/56 (53.6) | 215/486 (44.2) | 111/256 (43.4) |
| CABG | 95/871 (10.9) | 4//56 (7.1) | 52/486 (10.7) | 31/256 (12.1) |
| Medical therapy | 311/871 (35.7) | 15/56 (26.8) | 173/486 (35.6) | 87/256 (34.0) |
| Unknown | 89/871 (10.2) | 7/56 (12.5) | 46/486 (9.5) | 27/256 (10.5) |
| Treatment after angiography | ||||
| Revascularisation | 471/738 (63.8) | 34/48 (70.8) | 267/486 (67.6) | 142/229 (62.0) |
| PCI | 376/738 (50.9) | 30/48 (62.5) | 215/486 (54.4) | 111/229 (48.5) |
| CABG | 95/738 (12.9) | 4/48 (8.3) | 52/486 (13.2) | 31/229 (13.5) |
| Medical therapy | 209/738 (28.3) | 10/48 (20.8) | 104/486 (26.3) | 64/229 (27.9) |
| Unknown | 58/738 (7.9) | 4/48 (8.3) | 24/486 (6.1) | 23/229 (10.0) |
| Time indicators (hours) | ||||
| Time to coronary angiography | 24.0 (12.0–48.0) 636 pts | 2.0 (1.0–24.0) 40 pts | 24.0 (10–48.0) 337 pts | 24.0 (16.0–48.0) 196 pts |
| Time to PCI | 65.0 (21.8–120.0) 318 pts | 2.0 (1.0–33.0) 24 pts | 72 (24.0–120.0) 182 pts | 66.0 (24.0–120.0) 92 pts |
| Time to CABG | 216.5 (163.8–322.5) 24 pts | 217.0 (229.5–) 2 pts | 216 (169.5–381.0) 13 pts | 175.0 (78.5–298.8) 8 pts |
Values are number of cases (%) or median with interquartile range; time in hours
All patients were first admitted to a non-PCI centre. Coronary angiography at PCI centre indicates transfer from a non-PCI centre to a PCI centre with initial angiography at the PCI centre
ESC European Society of Cardiology, NSTE-ACS non ST-elevation acute coronary syndrome, PCI percutaneous coronary intervention, CABG coronary bypass grafting, pts patients
ainitial angiography at a non-PCI centre with additional angiography at a PCI centre for additional assessment (e. g. additional angiographic assessment, sometimes followed by intracoronary fractional flow reserves and/or coronary flow reserve measurements)